α-Synuclein target therapy (WaveBreak Therapeutics)

N/A

Report date: 2024/12/13 10:48:21
NME

Base Information

Drug Nameα-Synuclein target therapy (WaveBreak Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionSynuclein alpha inhibitors
TargetsSynuclein alpha
Therapy Area/IndicationsSynucleinopathiesParkinson DiseaseLewy Body Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWaveBreak Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWaveBreak Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsSynucleinopathiesParkinson DiseaseLewy Body Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A